Skip to main content
. 2023 Jun 28;110(10):1300–1308. doi: 10.1093/bjs/znad160

Table 3.

Reported methodological quality of included surgical randomized trials

1999 (n = 300) 2009 (n = 450) RR*† P†^ 2019 (n = 438) RR* P~
Primary outcome stated explicitly 203 (67.7) 297 (66.0) 0.98 (0.88, 1.08) 0.693 315 (71.9) 0.92 (0.84, 1.00) 0.057
Sample size calculation described 101 (33.7) 218 (48.4) 1.44 (1.20, 1.73) <0.001 296 (61.4) 0.72 (0.64, 0.80) <0.001
Baseline present 272 (90.7) 414 (92.0) 1.02 (0.97, 1.06) 0.594 412 (94.1) 0.98 (0.94, 1.01) 0.228
Generation of allocation: reported and adequate 96 (32.0) 213 (47.3) 1.48 (1.22, 1.79) <0.001 283 (64.6) 1.49 (1.28, 1.74) <0.001
 Computer 52 (17.3) 138 (30.7) 212 (48.4)
 Random table 24 (8.0) 30 (6.7) 41 (9.4)
 Other adequate 20 (6.7) 45 (10.0) 30 (6.8)
Concealment of allocation: reported and adequate 96 (32.0) 224 (50.0) 1.56 (1.29, 1.88) <0.001 287 (65.5) 0.76 (0.68, 0.85) <0.001
 Central/pharmacy 32 (10.7) 60 (13.3) 88 (20.1)
 Envelopes 57 (19.0) 145 (32.2) 140 (32.0)
 Other adequate 7 (2.3) 19 (4.2) 59 (13.5)
Blinding: any type of blinding 103 (34.3) 138 (30.7) 0.89 (0.73, 1.10) 0.300 181 (41.3) 0.74 (0.62, 0.89) 0.001
Double blinding stated 72 (24.0) 90 (20.0) 0.83 (0.63, 1.10) 0.205 71 (16.2) 0.81 (0.61, 1.07) 0.143
Type of analyses
 Intention to treat 60 (20.0) 149 (33.1) 1.66 (1.27, 2.15) <0.001 156 (35.6) 1.08 (0.90, 1.29) 0.432
 Per protocol 9 (3.0) 16 (3.6) 14 (3.2)
 Not stated 231 (77.0) 285 (63.3) 268 (61.2)
Handling of drop-outs adequate 253 (84.3) 373 (82.9) 1.01 (0.95, 1.07) 0.836 282 (64.4) 0.78 (0.72, 0.84) <0.001
 Low risk of bias 17 (5.7) 66 (14.7) 2.59 (1.55, 4.32) <0.001 97 (22.1) 1.51 (1.14, 2.01) 0.004

Values are n (%) unless indicated otherwise; *values in parentheses are 95% confidence intervals. †This comparison was performed in the authors’ previous study8. ^Comparing 1999 and 2009 using Fisher’s exact, χ2, and Mann–Whitney U tests. ~Comparing 2009 and 2019 using Fisher’s exact, χ2, and Mann–Whitney U tests. RR, relative rate.